levodopa has been researched along with Sleep Wake Disorders in 93 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (13.98) | 18.7374 |
1990's | 19 (20.43) | 18.2507 |
2000's | 31 (33.33) | 29.6817 |
2010's | 24 (25.81) | 24.3611 |
2020's | 6 (6.45) | 2.80 |
Authors | Studies |
---|---|
Acera, M; Ayala, U; Carmona, M; Del Pino, R; Fernández, M; Fernández, T; Gabilondo, I; Gómez-Esteban, JC; Murueta-Goyena, A; Tijero, B | 1 |
Kovrov, GV; Nodel, MR; Shevtsova, KV | 1 |
Kaminska, M; Lafontaine, AL; Scanga, A | 1 |
Batzu, L; Falup-Pecurariu, C; Leta, V; Qamar, MA; Ray Chaudhuri, K; Tall, P | 1 |
Kataoka, H; Kurumatani, N; Obayashi, K; Saeki, K; Sugie, K | 1 |
Becker, S; Berg, D; Busch, JH; Elshehabi, M; Emmert, K; Hansen, C; Liepelt-Scarfone, I; Maetzler, W; Nussbaum, S; Roeben, B; Schaeffer, E; Synofzik, M; Vaterrodt, T; Zaunbrecher, L | 1 |
Fu, YT; Huang, JY; Li, J; Liu, CF; Liu, JY; Ma, LJ; Mao, CJ; Wang, Y; Zhang, HJ | 1 |
Angrisano, S; Cicolin, A; Lopiano, L; Merola, A; Montanaro, E; Priano, L; Romagnolo, A; Tribolo, A; Zibetti, M | 1 |
Antonini, A; Ashkan, K; Dafsari, HS; Dembek, TA; Evans, J; Mahlstedt, P; Martinez-Martin, P; Ray-Chaudhuri, K; Rizos, A; Sachse, L; Silverdale, M; Steffen, J; Strack, M; Timmermann, L; Visser-Vandewalle, V | 1 |
Amato, N; Galati, S; Kaelin-Lang, A; Manconi, M; Möller, JC; Sarasso, S; Staedler, C; Stanzione, P | 1 |
Cantor, C; Chahine, LM; Colcher, A; Dahodwala, N; Daley, J; Duda, JE; Horn, S; Hurtig, H | 1 |
Antczak, JM; Banach, M; Derejko, M; Jakubczyk, T; Jernajczyk, W; Rakowicz, MJ; Sienkiewicz, J; Więcławska, M; Zalewska, U | 1 |
An, J; Chan, P; Gu, Z; Wang, C; Zhang, H | 1 |
Cohen, AD; Liu, W; Ye, M; Zhang, N; Zhang, Y | 1 |
Bauer, L; Chung, SJ; Ikeda, J; Jeon, BS; Kim, JM; Kim, JW; Singh, P; Thierfelder, S | 1 |
Baybas, S; Dirican, A; Dogan, GB; Dogan, VB; Koksal, A | 1 |
Adrien, J; Belaid, H; François, C; Hirsch, EC; Karachi, C | 1 |
Bird, LM; Tan, WH | 1 |
Bove, F; Espay, AJ; Espay, KJ; Fasano, A; Krikorian, R; Lena, F; Modugno, N; Poon, YY; Ricciardi, L | 1 |
Bonkowsky, JL; Chen, YC; Panula, P; Rozov, S; Semenova, S; Sundvik, M | 1 |
Zeitlhofer, J | 1 |
Sethi, K | 1 |
Comella, C; Elmer, L; Hauser, RA; Lyons, KE; Pahwa, R; Simuni, T; Weintraub, D | 1 |
Burn, DJ; McKeith, IG; Minett, T; Molloy, S; O'Brien, JT | 1 |
Brandauer, E; El-Demerdash, E; Frauscher, B; Gschliesser, V; Högl, B; Kaneider, M; Poewe, W; Rücker, L | 1 |
Audebert, C; Blin, O; Eusebio, A; Jouve, E; Micallef, J; Rey, M; Rouby, F; Tardieu, S | 1 |
Diederich, NJ; Fénelon, G; Goetz, CG; Stebbins, G | 1 |
Stacy, M | 1 |
Cardinali, DP; Merello, M; Perez-Lloret, S; Rossi, M; Santiago, PL | 1 |
Deuschl, G; Herzog, J; Volkmann, J; Wailke, S; Witt, K | 1 |
Brotchie, JM; Fox, SH | 1 |
Cronin-Golomb, A; Stavitsky, K | 1 |
Evers, S; Happe, S; Hornyak, M; Stiasny-Kolster, K | 1 |
Bloem, BR; Munneke, M; Petzinger, GM; Speelman, AD; van de Warrenburg, BP; van Nimwegen, M | 1 |
Fook-Chong, S; Lim, LL; Pavanni, R; Tan, EK; Yong, MH | 1 |
Schnitzler, A; Südmeyer, M; Wojtecki, L | 1 |
Li, M; Li, SD; Liu, Y; Yang, MH | 1 |
Bravo-Utrera, M; Burguera, JA; Campos-Arillo, VM; Chacón, JR; Durán-Herrera, C; Fernández-García, JM; García-Ramos, R; García-Ruiz, PJ; Gómez-Esteban, JC; Grandas, FJ; Gutierrez, J; Juni, J; Luquin, MR; Martí, MJ; Martínez-Castrillo, JC; Mata, M; Olivares, J; Ribacoba-Montero, R; Rojo, A; Santos-García, D; Sierra, M; Valero-Merino, C; Vela, L | 1 |
Mrowka, M; Odin, P; Shing, M | 1 |
Ongini, E | 1 |
Abdelgabar, A; Sharma, J | 1 |
De Mello, MT; Esteves, AM; Tufik, S | 1 |
Oertel, WH; Stiasny-Kolster, K | 1 |
Benbir, G; Kaynak, D; Kaynak, H; Kiziltan, G; Uysal, O | 1 |
Comella, CL; Janko, K; Morrissey, M | 1 |
Ludin, HP | 1 |
Schapira, AH | 1 |
Jansson, R; Nyholm, D; Remahl, IN; Willows, T | 1 |
Le Rhun, E; Lebert, F | 1 |
Bilbao, I; Ciordia, R; Gómez-Esteban, JC; Lezcano, E; Losada, J; Rouco, I; Velasco, F; Zarranz, JJ | 1 |
Diamond, A; Jankovic, J | 1 |
Borek, LL; Friedman, JH; Kohn, R | 1 |
Happe, S; Lanz, M | 1 |
Fertl, E | 1 |
Chan, DK; Cordato, DJ; O'Rourke, F | 1 |
Yung, CY | 1 |
Baum, R; Glantz, R; Klawans, HL; Nausieda, PA; Weber, S | 1 |
Brincat, S; Lang, AE; Marsden, CD; Parkes, JD; Quinn, N | 1 |
Chkili, T; el Alaoui-Faris, M; Nadifi, M; Ouahabi, H | 1 |
Allen, RP; Buchholz, DW; Kaplan, PW; Walters, JK | 1 |
Iivanainen, M; Kaakkola, S | 1 |
De Deyn, PP; Gonce, M; Jacquy, J; Van den Kerchove, M | 1 |
Kazenwadel, J; Kohnen, R; Krüger, HP; Künzel, M; Pollmächer, T; Ramm, S; Schwarz, J; Stiasny, K; Trenkwalder, C; Wetter, T | 1 |
Emrich, D; Hajak, G; Kögler, A; Munz, DL; Riemann, H; Rüther, E; Staedt, J; Stoppe, G | 1 |
Kazenwadel, J; Kohnen, R; Künzel, M; Oertel, WH; Pollmächer, T; Stiasny, K; Trenkwalder, C; Wetter, TC | 1 |
Fahn, S; Salgado, M; Tan, A | 1 |
Dowling, GA | 1 |
Lavigne, GJ; Lobbezoo, F; Montplaisir, JY; Tanguay, R | 1 |
Marsden, CD; Nordera, G; Stocchi, F | 1 |
Nozawa, T | 1 |
Barbato, L; Berardelli, A; Nordera, G; Ruggieri, S; Stocchi, F | 1 |
Amoiridis, G; Haan, J; Przuntek, H; Riess, O; Schöls, L | 1 |
Jönsson, R; Lindberg, E; Mallon, L; Nyström, B; Ulfberg, J | 1 |
Abele, M; Dichgans, J; Klockgether, T; Leonhardt, M; Weller, M | 1 |
Ellis, CM; Ray Chaudhuri, K; Reuter, I | 1 |
Karlsen, K; Larsen, JP; Tandberg, E | 1 |
Castro-Caldas, A; Ferreira, JJ; Montastruc, JL; Rascol, O; Thalamas, C | 1 |
Bergamasco, B; Lanotte, M; Lopiano, L; Melcarne, A; Perozzo, P; Rizzone, M; Tavella, A; Torre, A | 1 |
Díaz, V; Miranda, M; Venegas, P; Villagra, R | 1 |
Bailbé, M; Dumas, P; Gil, R; Karolewicz, S; Neau, JP | 1 |
Balestre, E; Bioulac, B; Chrysostome, V; Ghorayeb, I; Tison, F; Yekhlef, F | 1 |
Clark, RW; Malarkey, WB; Schmidt, HS | 1 |
Lapierre, O; Montplaisir, J; Pelletier, G; Warnes, H | 1 |
Pfeiffer, R | 1 |
Costeff, H; Gadoth, N; Harel, S; Lavie, P | 1 |
Boivin, DB; Montplaisir, J; Poirier, G | 1 |
Bédard, MA; Godbout, R; Montplaisir, J; Poirier, G | 1 |
Klawans, HL | 1 |
Sandyk, R | 1 |
Askenasy, JJ; Yahr, MD | 1 |
AuAutret, A | 1 |
Baker, AB; Loewenson, RB; Martin, WE; Resch, JA | 1 |
Fischer, PA; Jacobi, P; Maxion, H; Schneider, E | 1 |
28 review(s) available for levodopa and Sleep Wake Disorders
Article | Year |
---|---|
An overview of the effects of levodopa and dopaminergic agonists on sleep disorders in Parkinson's disease.
Topics: Dopamine Agonists; Humans; Levodopa; Neurodegenerative Diseases; Parkinson Disease; Quality of Life; Sleep Wake Disorders | 2023 |
Non-oral continuous drug delivery based therapies and sleep dysfunction in Parkinson's disease.
Topics: Antiparkinson Agents; Dopamine; Humans; Levodopa; Parkinson Disease; Sleep; Sleep Wake Disorders | 2023 |
Pharmacological therapies for Angelman syndrome.
Topics: Angelman Syndrome; Animals; Clinical Trials as Topic; Disease Models, Animal; Gene Silencing; Levodopa; Mice; Minocycline; Oligoribonucleotides, Antisense; Seizures; Sleep Wake Disorders; Topoisomerase Inhibitors; Ubiquitin-Protein Ligases | 2017 |
Levodopa unresponsive symptoms in Parkinson disease.
Topics: Antiparkinson Agents; Anxiety; Depression; Dyskinesia, Drug-Induced; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Parkinson Disease; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Sweating; Xerostomia | 2008 |
Treatment of early Parkinson's disease. Part 2.
Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Clinical Trials as Topic; Cognition Disorders; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Olfaction Disorders; Pain; Parkinson Disease; Psychotic Disorders; Sleep Wake Disorders; Time Factors | 2009 |
Hallucinations in Parkinson disease.
Topics: Animals; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Hallucinations; Humans; Illusions; Levodopa; Magnetic Resonance Imaging; Neurotransmitter Agents; Parkinson Disease; Sleep Wake Disorders | 2009 |
The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future.
Topics: alpha-Synuclein; Animals; Antiparkinson Agents; Basal Ganglia; Cognition Disorders; Disease Models, Animal; Dopamine; Drug Discovery; Endpoint Determination; Humans; Levodopa; Movement; MPTP Poisoning; Neurons; Neuroprotective Agents; Parkinson Disease, Secondary; Primates; Psychoses, Substance-Induced; Sleep Wake Disorders | 2010 |
[Restless legs syndrome and nocturnal leg pain : Differential diagnosis and treatment].
Topics: Anticonvulsants; Circadian Rhythm; Comorbidity; Cross-Sectional Studies; Diagnosis, Differential; Dopamine Agonists; Humans; Leg; Levodopa; Pain; Restless Legs Syndrome; Risk Factors; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders | 2011 |
How might physical activity benefit patients with Parkinson disease?
Topics: Antiparkinson Agents; Cardiovascular Diseases; Cognition; Constipation; Depressive Disorder; Dopamine; Humans; Levodopa; Motor Activity; Muscle Fatigue; Osteoporosis; Parkinson Disease; Psychomotor Performance; Quality of Life; Sedentary Behavior; Sleep Wake Disorders | 2011 |
[Current treatment strategies for Parkinson's disease].
Topics: Aged; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Apomorphine; Critical Care; Deep Brain Stimulation; Dementia; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Europe; Female; Humans; Infusion Pumps, Implantable; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Psychotic Disorders; Sleep Wake Disorders; Tremor | 2011 |
[Levodopa in the treatment of Parkinson's disease: myths and realties].
Topics: Antiparkinson Agents; Humans; Levodopa; Mental Disorders; Motor Activity; Parkinson Disease; Quality of Life; Sleep Wake Disorders | 2012 |
Restless legs syndrome.
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Child; Diagnosis, Differential; Dopamine Agonists; Humans; Levodopa; Narcotics; Nervous System Diseases; Neurologic Examination; Polysomnography; Restless Legs Syndrome; Sleep Wake Disorders | 2002 |
Sleep disorders in Parkinson's disease.
Topics: Antiparkinson Agents; Humans; Levodopa; Pain; Parkinson Disease; Quality of Life; Sleep; Sleep Wake Disorders | 2003 |
[Idiopathic Parkinson's disease: practical hints for the treatment].
Topics: Adult; Aged; Antidepressive Agents; Antiparkinson Agents; Antipsychotic Agents; Benserazide; Cholinesterase Inhibitors; Clozapine; Dementia; Depression; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Drug Combinations; Humans; Levodopa; Parkinson Disease; Quality of Life; Sleep Wake Disorders; Time Factors | 2005 |
Present and future drug treatment for Parkinson's disease.
Topics: Benzothiazoles; Corpus Striatum; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Humans; Indans; Indoles; Levodopa; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Pramipexole; Psychomotor Performance; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Substantia Nigra; Thiazoles; Urinary Incontinence | 2005 |
[Treatment of dementia with Lewy bodies].
Topics: Antiparkinson Agents; Antipsychotic Agents; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Case Management; Cholinesterase Inhibitors; Combined Modality Therapy; Drug Resistance; Drug Therapy, Combination; Hallucinations; Humans; Levodopa; Lewy Body Disease; Mental Disorders; Mood Disorders; Nootropic Agents; Physical Therapy Modalities; Sleep Wake Disorders; Speech Therapy | 2006 |
Treatment of advanced Parkinson's disease.
Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Cognition Disorders; Humans; Levodopa; Mental Disorders; Parkinson Disease; Sleep Wake Disorders | 2006 |
[When the legs have to keep moving at night--the restless legs syndrome].
Topics: Adult; Amines; Analgesics, Opioid; Anticonvulsants; Child; Cyclohexanecarboxylic Acids; Dopamine Agonists; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Levodopa; Male; Middle Aged; Polysomnography; Pregnancy; Quality of Life; Restless Legs Syndrome; Sleep Wake Disorders; Time Factors | 2007 |
Management for motor and non-motor complications in late Parkinson's disease.
Topics: Accidental Falls; Aged; Antiparkinson Agents; Comorbidity; Dementia; Dyskinesias; Humans; Hypotension, Orthostatic; Levodopa; Parkinson Disease; Sleep Wake Disorders | 2008 |
A review of clinical trials of lithium in neurology.
Topics: Clinical Trials as Topic; Cluster Headache; Dyskinesia, Drug-Induced; Epilepsy; Headache; Humans; Huntington Disease; Hyperkinesis; Levodopa; Lithium; Meniere Disease; Migraine Disorders; Movement Disorders; Nervous System Diseases; Neurocognitive Disorders; Parkinson Disease; Sleep Wake Disorders; Torticollis | 1984 |
[L-dopa-responsive dystonia: 2 familial cases of adult onset with sleep disorders].
Topics: Adult; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Sleep Wake Disorders | 1995 |
Strategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias.
Topics: Antiparkinson Agents; Apomorphine; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Enzyme Inhibitors; Globus Pallidus; Humans; Levodopa; Mental Disorders; Movement Disorders; Parkinson Disease; Sleep Wake Disorders; Stereotaxic Techniques; Thalamus | 1997 |
[Periodic limb movement disorder].
Topics: Anticonvulsants; Clonazepam; Diagnosis, Differential; Dopamine Agents; Humans; Levodopa; Movement Disorders; Periodicity; Polysomnography; Restless Legs Syndrome; Sleep Wake Disorders | 1998 |
Sleep disorders in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Aging; Antiparkinson Agents; Clinical Trials as Topic; Humans; Levodopa; Middle Aged; Motor Activity; Muscle, Skeletal; Parkinson Disease; Respiration; Sleep Wake Disorders | 1998 |
[Restless legs. A much neglected syndrome].
Topics: Adolescent; Adult; Anticonvulsants; Clonazepam; Dopamine Agents; Humans; Levodopa; Polysomnography; Restless Legs Syndrome; Sleep Wake Disorders; Terminology as Topic | 1999 |
The treatment of the restless leg syndrome with or without periodic leg movements in sleep.
Topics: Anti-Anxiety Agents; Clonazepam; Dextropropoxyphene; Dopamine Agents; Humans; Levodopa; Narcotics; Polysomnography; Restless Legs Syndrome; Sleep Stages; Sleep Wake Disorders | 1992 |
Optimization of levodopa therapy.
Topics: Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Drug Interactions; Gastrointestinal Diseases; Humans; Hypotension, Orthostatic; Levodopa; Mental Disorders; Sleep Wake Disorders | 1992 |
Psychiatric side effects during the treatment of Parkinson's disease.
Topics: Dreams; Dyskinesia, Drug-Induced; Hallucinations; Humans; Levodopa; Mental Disorders; Paranoid Disorders; Parkinson Disease; Serotonin; Severity of Illness Index; Sleep Wake Disorders | 1988 |
22 trial(s) available for levodopa and Sleep Wake Disorders
Article | Year |
---|---|
The heterogeneity of non-motor symptoms of Parkinson's disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Asian People; Digestive System Abnormalities; Female; Humans; Levodopa; Male; Mental Status Schedule; Metabolic Diseases; Middle Aged; Mood Disorders; Parkinson Disease; Retrospective Studies; Sensation Disorders; Severity of Illness Index; Sleep Wake Disorders; Young Adult | 2015 |
Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson's disease: an open-label study.
Topics: Activities of Daily Living; Administration, Cutaneous; Aged; Benzothiazoles; Dopamine Agonists; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Sleep Wake Disorders; Tetrahydronaphthalenes; Thiophenes | 2015 |
Levodopa use and sleep in patients with dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Levodopa; Lewy Body Disease; Male; Mental Status Schedule; Parkinson Disease; Severity of Illness Index; Sleep Wake Disorders; Surveys and Questionnaires; Time Factors | 2009 |
Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects.
Topics: Adolescent; Adult; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cross-Over Studies; Double-Blind Method; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Pramipexole; Sleep Wake Disorders; Treatment Outcome; Young Adult | 2009 |
Effect of controlled-release levodopa on the microstructure of sleep in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Carbidopa; Delayed-Action Preparations; Dopamine Agonists; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Sleep; Sleep Wake Disorders | 2011 |
[Effects of bushenhuoxue granules on sleep quality in Parkinson's patients].
Topics: Aged; Aged, 80 and over; Benserazide; Double-Blind Method; Drug Combinations; Drugs, Chinese Herbal; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Phytotherapy; Plants, Medicinal; Polysomnography; Severity of Illness Index; Sleep Wake Disorders; Treatment Outcome | 2011 |
Comparison between dopaminergic agents and physical exercise as treatment for periodic limb movements in patients with spinal cord injury.
Topics: Adult; Dopamine Agents; Drug Administration Schedule; Exercise; Extremities; Female; Follow-Up Studies; Humans; Injury Severity Score; Levodopa; Male; Middle Aged; Movement; Polysomnography; Probability; Prospective Studies; Risk Assessment; Sleep Wake Disorders; Spinal Cord Injuries; Treatment Outcome | 2004 |
Low-dose pramipexole in the management of restless legs syndrome. An open label trial.
Topics: Administration, Oral; Aged; Antiparkinson Agents; Benzothiazoles; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Levodopa; Male; Middle Aged; Polysomnography; Pramipexole; Restless Legs Syndrome; Severity of Illness Index; Sleep Wake Disorders; Thiazoles; Treatment Outcome | 2004 |
Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment.
Topics: Age Factors; Aged; Aged, 80 and over; Antiparkinson Agents; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Polysomnography; Prospective Studies; Sleep Stages; Sleep Wake Disorders | 2005 |
Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy.
Topics: Age Factors; Aged; Antiparkinson Agents; Brain; Circadian Rhythm; Constipation; Dizziness; Dopamine Agonists; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Pergolide; Placebos; Sex Factors; Sleep; Sleep Wake Disorders; Treatment Outcome | 2005 |
A review of clinical trials of lithium in neurology.
Topics: Clinical Trials as Topic; Cluster Headache; Dyskinesia, Drug-Induced; Epilepsy; Headache; Humans; Huntington Disease; Hyperkinesis; Levodopa; Lithium; Meniere Disease; Migraine Disorders; Movement Disorders; Nervous System Diseases; Neurocognitive Disorders; Parkinson Disease; Sleep Wake Disorders; Torticollis | 1984 |
Pergolide in late-stage Parkinson disease.
Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Sleep Wake Disorders | 1982 |
A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene.
Topics: Adult; Aged; Carbidopa; Dextropropoxyphene; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Movement; Polysomnography; Reaction Time; Restless Legs Syndrome; Sleep Wake Disorders; Time Factors | 1993 |
L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial.
Topics: Adult; Aged; Antiparkinson Agents; Benserazide; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Electroencephalography; Female; Humans; Levodopa; Male; Middle Aged; Polysomnography; Quality of Life; Restless Legs Syndrome; Sleep Wake Disorders; Uremia | 1995 |
Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS).
Topics: Aged; Benzamides; Brain; Brain Chemistry; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Middle Aged; Myoclonus; Polysomnography; Pyrrolidines; Receptors, Dopamine D2; Sleep Wake Disorders; Tomography, Emission-Computed, Single-Photon | 1995 |
[Treatment of idiopathic and uremic restless legs syndrome with L-dopa--a double-blind cross-over study].
Topics: Administration, Oral; Adult; Aged; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Polysomnography; Quality of Life; Restless Legs Syndrome; Sleep Wake Disorders; Uremia | 1995 |
The effect of catecholamine precursor L-dopa on sleep bruxism: a controlled clinical trial.
Topics: Adult; Benserazide; Bruxism; Cross-Over Studies; Dopamine Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Electromyography; Female; Humans; Levodopa; Male; Polysomnography; Sleep Wake Disorders | 1997 |
Sleep disorders in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Aging; Antiparkinson Agents; Clinical Trials as Topic; Humans; Levodopa; Middle Aged; Motor Activity; Muscle, Skeletal; Parkinson Disease; Respiration; Sleep Wake Disorders | 1998 |
Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome.
Topics: Adult; Aged; Antiparkinson Agents; Apomorphine; Drug Administration Schedule; Follow-Up Studies; Humans; Injections, Subcutaneous; Levodopa; Middle Aged; Parkinson Disease; Restless Legs Syndrome; Sleep Wake Disorders | 1999 |
The effects of L-dopa on periodic leg movements and sleep organization in narcolepsy.
Topics: Adolescent; Adult; Double-Blind Method; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Narcolepsy; Sleep; Sleep Wake Disorders; Sleep, REM | 1989 |
A controlled study comparing trihexyphenidyl hydrochloride plus levodopa with placebo plus levodopa in patients with Parkinson's disease.
Topics: Affective Symptoms; Aged; Anxiety; Clinical Trials as Topic; Confusion; Drug Evaluation; Drug Therapy, Combination; Female; Hallucinations; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Placebos; Sleep Wake Disorders; Time Factors; Trihexyphenidyl; Vomiting | 1974 |
Effect of melanocyte-stimulating hormone-release inhibiting factor (MIF) in Parkinson's syndrom.
Topics: Aged; Amides; Aromatic Amino Acid Decarboxylase Inhibitors; Behavior; Clinical Trials as Topic; Depression; Dopa Decarboxylase; Female; Follow-Up Studies; Humans; Injections, Intravenous; Levodopa; Male; Melanocyte-Stimulating Hormones; Middle Aged; Oligopeptides; Parkinson Disease; Pituitary Hormone-Releasing Hormones; Placebos; Psychomotor Disorders; Sleep Wake Disorders | 1974 |
45 other study(ies) available for levodopa and Sleep Wake Disorders
Article | Year |
---|---|
Clinical long-term nocturnal sleeping disturbances and excessive daytime sleepiness in Parkinson's disease.
Topics: Age Factors; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Photoperiod; Sex Factors; Sleep Wake Disorders | 2021 |
[The factors impact on the urgent daytime sleepiness degree in the Parkinson's disease].
Topics: Aged; Disorders of Excessive Somnolence; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine; Sleep Wake Disorders; Sleepiness | 2022 |
Objective sleep measures between patients with Parkinson's disease and community-based older adults.
Topics: Aged; Cross-Sectional Studies; Humans; Levodopa; Parkinson Disease; Polysomnography; Sleep; Sleep Wake Disorders | 2020 |
Effects of Levodopa on quality of sleep and nocturnal movements in Parkinson's Disease.
Topics: Antiparkinson Agents; Humans; Levodopa; Movement; Parkinson Disease; Sleep; Sleep Wake Disorders | 2021 |
Pain Correlates with Sleep Disturbances in Parkinson's Disease Patients.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Depression; Female; Humans; Levodopa; Logistic Models; Male; Middle Aged; Musculoskeletal Pain; Pain; Pain Measurement; Parkinson Disease; Polysomnography; Quality of Life; Sleep; Sleep Wake Disorders; Sleep, REM | 2018 |
A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion.
Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Intestines; Levodopa; Male; Mental Status and Dementia Tests; Middle Aged; Parkinsonian Disorders; Polysomnography; Severity of Illness Index; Sleep Wake Disorders; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome | 2017 |
Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Cardiovascular Abnormalities; Deep Brain Stimulation; Female; Humans; International Cooperation; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Quality of Life; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Subthalamic Nucleus; Surveys and Questionnaires; Treatment Outcome | 2018 |
Levodopa-induced dyskinesia in Parkinson disease: Sleep matters.
Topics: Actigraphy; Adult; Aged; Antiparkinson Agents; Depression; Dyskinesia, Drug-Induced; Electroencephalography; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Psychiatric Status Rating Scales; Sleep Wake Disorders; Statistics, Nonparametric | 2018 |
Association between dopaminergic medications and nocturnal sleep in early-stage Parkinson's disease.
Topics: Age of Onset; Aged; Antiparkinson Agents; Cross-Sectional Studies; Dopamine Agents; Female; Humans; Hypnotics and Sedatives; Levodopa; Male; Middle Aged; Multivariate Analysis; Parkinson Disease; Polysomnography; Sleep; Sleep Stages; Sleep Wake Disorders; Sleep, REM | 2013 |
Negative influence of L-dopa on subjectively assessed sleep but not on nocturnal polysomnography in Parkinson's disease.
Topics: Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Severity of Illness Index; Sleep; Sleep Wake Disorders; Surveys and Questionnaires | 2013 |
Non-motor symptoms in treated and untreated Chinese patients with early Parkinson's disease.
Topics: Age Factors; Antiparkinson Agents; China; Cohort Studies; Constipation; Depression; Dopamine Agonists; Humans; Levodopa; Logistic Models; Parkinson Disease; Sex Factors; Sleep Wake Disorders; Time Factors | 2014 |
Independent effect of fatigue on health-related quality of life in patients with idiopathic Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Depression; Depressive Disorder; Fatigue; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Quality of Life; Severity of Illness Index; Sleep Wake Disorders; Surveys and Questionnaires | 2015 |
Effect of melatonin on sleep disorders in a monkey model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Central Nervous System Depressants; Disease Models, Animal; Levodopa; Macaca fascicularis; Male; Melatonin; Parkinson Disease; Sleep Wake Disorders | 2015 |
24-Hour infusion of levodopa/carbidopa intestinal gel for nocturnal akinesia in advanced Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Muscle Rigidity; Outcome Assessment, Health Care; Parkinson Disease; Sleep Wake Disorders | 2016 |
A Novel Developmental Role for Dopaminergic Signaling to Specify Hypothalamic Neurotransmitter Identity.
Topics: Animals; Dopaminergic Neurons; Histamine; Hypothalamus; Levodopa; Neurotransmitter Agents; Orexins; Parkinson Disease; Serotonergic Neurons; Sleep Wake Disorders; Synaptic Transmission; Tyrosine 3-Monooxygenase; Zebrafish; Zebrafish Proteins | 2016 |
[Treatment of the restless legs syndrome].
Topics: Anticonvulsants; Diagnosis, Differential; Dopamine Agonists; Family Practice; Humans; Levodopa; Narcotics; Paresthesia; Polysomnography; Psychomotor Agitation; Restless Legs Syndrome; Sleep Wake Disorders | 2008 |
The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels.
Topics: Aged; Biomarkers; Cohort Studies; Disease Progression; Dopamine Agents; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Ferritins; Humans; Levodopa; Male; Middle Aged; Prospective Studies; Restless Legs Syndrome; Severity of Illness Index; Sleep Wake Disorders | 2009 |
Medical treatment of Parkinson disease.
Topics: Amantadine; Antiparkinson Agents; Catechol O-Methyltransferase Inhibitors; Cognition Disorders; Corpus Striatum; Digestive System Physiological Phenomena; Dopamine Agonists; Enzyme Inhibitors; Humans; Hypotension, Orthostatic; Levodopa; Mental Disorders; Monoamine Oxidase Inhibitors; Motor Activity; Movement Disorders; Neurons; Parkinson Disease; Sleep Wake Disorders; Substantia Nigra | 2009 |
Activity-rest rhythm abnormalities in Parkinson's disease patients are related to dopaminergic therapy.
Topics: Actigraphy; Activities of Daily Living; Aged; Case-Control Studies; Circadian Rhythm; Dopamine Agents; Female; Humans; Levodopa; Male; Pain Measurement; Parkinson Disease; Polysomnography; Predictive Value of Tests; Psychiatric Status Rating Scales; Sleep Wake Disorders; Statistics, Nonparametric; Wakefulness | 2010 |
Sleep quality in Parkinson disease: an examination of clinical variables.
Topics: Actigraphy; Aged; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Sleep; Sleep Wake Disorders; Surveys and Questionnaires | 2011 |
Case control polysomnographic studies of sleep disorders in Parkinson's disease.
Topics: Aged; Case-Control Studies; Female; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Polysomnography; REM Sleep Behavior Disorder; Respiration; Restless Legs Syndrome; Sex Characteristics; Sleep Wake Disorders; Surveys and Questionnaires | 2011 |
Adenosine A(2A) receptors in nonlocomotor features of Parkinson's disease: introduction.
Topics: Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Central Nervous System; Depression; Dyskinesia, Drug-Induced; Humans; Hypotension, Orthostatic; Levodopa; Parkinson Disease; Receptor, Adenosine A2A; Sleep Wake Disorders | 2003 |
Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
Topics: Akinetic Mutism; Antiparkinson Agents; Chronobiology Disorders; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Duodenum; Humans; Infusion Pumps; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Sleep Wake Disorders; Time; Time Factors; Treatment Outcome | 2005 |
Sleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Cross-Sectional Studies; Dopamine Agents; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Sickness Impact Profile; Sleep Wake Disorders; Statistics as Topic | 2006 |
Phenomenology of dreams in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Cognition Disorders; Dreams; Female; Humans; Levodopa; Male; Neuropsychological Tests; Parkinson Disease; Semantics; Severity of Illness Index; Sleep Wake Disorders; Sleep, REM | 2007 |
Comment to the paper of Medeiros CAM, et al. (2007) J Neurol 254:459-464.
Topics: Antiparkinson Agents; Central Nervous System Depressants; Circadian Rhythm; Drug Administration Schedule; Drug Interactions; Humans; Levodopa; Melatonin; Parkinson Disease; Placebo Effect; Randomized Controlled Trials as Topic; Sleep; Sleep Wake Disorders; Time Factors | 2008 |
Psychiatric complications of levodopa therapy of Parkinson's disease.
Topics: Circadian Rhythm; Hallucinations; Humans; Hydrocortisone; Levodopa; Mental Disorders; Mood Disorders; Parkinson Disease; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Thinking | 1984 |
Dopa-responsive dystonia of childhood.
Topics: Adolescent; Biopterins; Child; Child, Preschool; Diagnosis, Differential; Dystonia; Electromyography; Female; Gait; Humans; Infant; Levodopa; Male; Muscle Tonus; Polysomnography; Posture; Sex Factors; Sleep Wake Disorders; Synaptic Transmission | 1993 |
Sustained-release levodopa in parkinsonian patients with nocturnal disabilities.
Topics: Aged; Aged, 80 and over; Delayed-Action Preparations; Humans; Levodopa; Longitudinal Studies; Middle Aged; Movement Disorders; Parkinson Disease; Sleep Wake Disorders | 1993 |
Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa.
Topics: Aged; Antiparkinson Agents; Humans; Levodopa; Male; Neurologic Examination; Parkinson Disease; Sleep Wake Disorders; Sleep, REM | 1996 |
Sleep in older women with Parkinson's disease.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Circadian Rhythm; Cross-Sectional Studies; Female; Humans; Levodopa; Middle Aged; Nursing Assessment; Parkinson Disease; Sleep Stages; Sleep Wake Disorders; Wakefulness | 1995 |
Sleep disturbance in spinocerebellar ataxias: is the SCA3 mutation a cause of restless legs syndrome?
Topics: Adult; Aged; Dopamine Agents; Electrophysiology; Female; Genes, Dominant; Humans; Levodopa; Machado-Joseph Disease; Male; Middle Aged; Mutation; Polysomnography; Restless Legs Syndrome; Sleep Wake Disorders | 1998 |
Pathological yawning (chasm) associated with periodic leg movements in sleep: cure by levodopa.
Topics: Adult; Compulsive Behavior; Dopamine Agents; Fatigue; Female; Humans; Levodopa; Restless Legs Syndrome; Sleep Wake Disorders; Yawning | 1999 |
Clinical problems in non-fluctuating patients with Parkinson's disease: a community-based study.
Topics: Age of Onset; Aged; Antiparkinson Agents; Case-Control Studies; Dementia; Depression; Diabetes Mellitus; Drug Tolerance; Fatigue; Female; Humans; Levodopa; Male; Movement Disorders; Neurologic Examination; Norway; Outpatients; Parkinson Disease; Prevalence; Psychomotor Performance; Quality of Life; Severity of Illness Index; Sleep Wake Disorders; Surveys and Questionnaires | 2000 |
Levodopa monotherapy can induce "sleep attacks" in Parkinson's disease patients.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sleep Wake Disorders | 2001 |
Daytime sleepiness improvement following bilateral chronic electrical stimulation of the subthalamic nucleus in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Electric Stimulation Therapy; Humans; Levodopa; Male; Parkinson Disease; Sleep Wake Disorders; Subthalamic Nucleus | 2001 |
[Sleepiness attacks while driving: adverse effects of new antiparkinson drugs].
Topics: Antiparkinson Agents; Automobile Driving; Female; Humans; Levodopa; Middle Aged; Parkinson Disease; Sleep Wake Disorders | 2001 |
[Hallucinations, delusions, and nocturnal events in 152 Parkinson's patients: a regional survey].
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Delusions; Female; France; Hallucinations; Health Surveys; Humans; Inpatients; Levodopa; Male; Middle Aged; Outpatients; Paranoid Disorders; Parkinson Disease; Severity of Illness Index; Sleep Wake Disorders | 2002 |
Sleep disorders and their determinants in multiple system atrophy.
Topics: Aged; Antiparkinson Agents; Depression; Female; Humans; Incidence; Levodopa; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Severity of Illness Index; Sleep Wake Disorders | 2002 |
Disordered growth hormone and prolactin secretion in primary disorders of sleep.
Topics: Adult; Apnea; Arginine; Arousal; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Narcolepsy; Prolactin; Sleep Stages; Sleep Wake Disorders | 1979 |
Motor abnormalities during sleep in patients with childhood hereditary progressive dystonia, and their unaffected family members.
Topics: Adolescent; Adult; Aged; Antiparkinson Agents; Basal Ganglia; Carbidopa; Child; Child, Preschool; Drug Combinations; Dystonia; Female; Genetic Carrier Screening; Humans; Levodopa; Male; Middle Aged; Motor Activity; Sleep Stages; Sleep Wake Disorders; Sleep, REM | 1989 |
Restless legs syndrome and periodic movements in sleep: physiopathology and treatment with L-dopa.
Topics: Adult; Central Nervous System; Dopamine; Female; Humans; Levodopa; Male; Movement Disorders; Restless Legs Syndrome; Sleep Wake Disorders; Sodium Oxybate; Synaptic Transmission | 1986 |
Serotonergic mechanisms in levodopa-induced "on-off" and sleep disorders in Parkinson's disease.
Topics: Amitriptyline; Female; Humans; Levodopa; Middle Aged; Parkinson Disease; Serotonin; Sleep Wake Disorders | 1988 |
Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy: a preliminary study.
Topics: Aged; Carbidopa; Drug Combinations; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Receptors, Dopamine; Sleep Wake Disorders; Sleep, REM | 1985 |
[Sleep: recent physiological acquisitions and clinical and pharmacological perspectives].
Topics: Animals; Brain; Cerebral Cortex; Electrocardiography; Electroencephalography; Electromyography; Electrooculography; Environment; Forecasting; Humans; Levodopa; Mental Disorders; Mesencephalon; Neurotransmitter Agents; Norepinephrine; Rats; Respiration; Reticular Formation; Sleep; Sleep Deprivation; Sleep Wake Disorders; Sleep, REM; Substance-Related Disorders; Telencephalon | 1974 |